PharmTech Drug Digest 11.20

Regulatory Oversight and Compliance

Latest News


Latest Videos


Shorts

PharmTech AI Pulse Check
0:44
The Need for An AI Playbook
2 days ago
by
Richard Jaenisch(+4 more)
PharmTech AI Pulse Check
0:39
Who Validates the Regulators Using AI?
4 days ago
by
Richard Jaenisch(+4 more)
PharmTech AI Pulse Check
0:25
Why Universal AI Training Doesn't Work
8 days ago
by
Richard Jaenisch(+4 more)
Manish Baviskar, senior validation engineer, Hubot CDMO
0:35
The Checklist to Validate AI in GMP Enviorments
13 days ago
by
Manish Baviskar
Ron Filler, Drug Development Consultants
0:46
Navigating Novel Excipients -The Safety Guide
16 days ago
by
Ron Filler
Manish Baviskar, senior validation engineer, Hubot CDMO
0:46
AI vs. Traditional Software in Pharma
16 days ago
by
Manish Baviskar
Nine duloxetine recalls since 2024 show why generic drug manufacturers need route-level nitrosamine risk assessment, not end-product testing alone.
0:31
New Solutions to the Drug Recall Crisis
23 days ago
by
Zachary Zubulake(+2 more)
Nine duloxetine recalls since 2024 show why generic drug manufacturers need route-level nitrosamine risk assessment, not end-product testing alone.
1:01
How to Stop the Next Nitrosamine Drug Recall
25 days ago
by
Zachary Zubulake(+2 more)
Nine duloxetine recalls since 2024 show why generic drug manufacturers need route-level nitrosamine risk assessment, not end-product testing alone.
0:42
The Hidden Danger in Generic Antidepressants
a month ago
by
Zachary Zubulake

More News